Diversified Trust CO Lantheus Holdings, Inc. Transaction History

Diversified Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$82.41 - $99.65 $200,668 - $242,647	2,435 New	2,435 $204,000
Q3 2022 Oct 14, 2022	SELL	$61.42 - $86.29 $237,818 - $334,114	-3,872 Reduced 28.35%	9,785 $688,000
Q2 2022 Jul 12, 2022	BUY	$55.54 - $72.65 $1,999 - $2,615	36 Added 0.26%	13,657 $902,000
Q1 2022 Apr 07, 2022	SELL	$24.28 - $56.64 $9,469 - $22,089	-390 Reduced 2.78%	13,621 $753,000
Q4 2021 Jan 13, 2022	BUY	$22.54 - $30.44 $21,525 - $29,070	955 Added 7.31%	14,011 $405,000
Q1 2021 May 10, 2021	SELL	$13.77 - $21.66 $18,506 - $29,111	-1,344 Reduced 9.33%	13,056 $279,000
Q4 2020 Jan 08, 2021	BUY	$10.75 - $14.91 $154,800 - $214,704	14,400 New	14,400 $194,000
Q3 2020 Oct 15, 2020	SELL	$11.98 - $16.34 $129,659 - $176,847	-10,823 Closed	0 $0
Q2 2020 Jul 07, 2020	BUY	$10.34 - $15.51 $111,909 - $167,864	10,823 New	10,823 $155,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.59B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.